For the year ending 2025-12-31, ROG had $37.2M increase in cash & cash equivalents over the period. $71.1M in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | -61.8 |
| Depreciation and amortization | 54.3 |
| Equity compensation expense | 10.9 |
| Deferred income taxes | -6.7 |
| Equity in undistributed income of unconsolidated joint ventures | 0 |
| Dividends received from unconsolidated joint ventures | 0 |
| Gain on jv separation agreement transactions | 0 |
| Gain on sale of business | 0 |
| (gain) loss on sale or disposal of property, plant and equipment | 0 |
| Impairment charges | 73.7 |
| Other non-cash charges, net | -0.2 |
| Accounts receivable | -10.8 |
| Proceeds from insurance related to operations | 0 |
| Contract assets | 2.3 |
| Inventories, net | -23.4 |
| Other current assets | -1 |
| Accounts payable and other accrued expenses | 0.8 |
| Other, net | 2.7 |
| Net cash provided by operating activities | 101.2 |
| Capital expenditures | 30.1 |
| Disposition of business | 0 |
| Net cash from jv separation agreement transactions | 0 |
| Proceeds from the sale of marketable equity securities | 1.3 |
| Purchases of marketable equity securities | 0.2 |
| Proceeds from the sale of property, plant and equipment, net | 14.2 |
| Proceeds from insurance claims | 0 |
| Net cash used in investing activities | -14.8 |
| Repayment of debt principal and finance lease obligations | 1.3 |
| Line of credit issuance costs | 0 |
| Payments of taxes related to net share settlement of equity awards | 1.4 |
| Proceeds from issuance of shares to employee stock purchase plan | 1.2 |
| Share repurchases | 52.4 |
| Net cash used in financing activities | -53.9 |
| Effect of exchange rate fluctuations on cash | 4.7 |
| Net increase (decrease) in cash and cash equivalents | 37.2 |
| Cash and cash equivalents at beginning of period | 159.8 |
| Cash and cash equivalents at end of period | 197 |
ROGERS CORP (ROG)
ROGERS CORP (ROG)